Concepedia

Björn Landfeldt

BL

5

Publications

470

Citations

5

H-Index

2001

Active since

Affiliations

Pfizer (Sweden)(Current)

Björn Landfeldt is an author at Pfizer (Sweden) specializing in tobacco cessation, cardiovascular risk factors, and public health.

Top concepts

Publications per year

2001–2006

5

Publications

5

Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo‐controlled trial of nicotine gum with 2‐year follow‐up

Poul Wennike, Tobias Danielsson, Björn Landfeldt et al. · Addiction · 2003 · 164 citations

Effect of smoking reduction and cessation on cardiovascular risk factors

Björn Eliasson, Agneta Hjalmarson, Elisabeth Kruse et al. · Nicotine & Tobacco Research · 2001 · 110 citations

, , +9

Smoking reduction treatment with 4-mg nicotine gum: A double-blind, randomized, placebo-controlled study

Anil Batra, K Klingler, Björn Landfeldt et al. · Clinical Pharmacology & Therapeutics · 2005 · 95 citations

Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial

Stephen I. Rennard, Elbert D. Glover, Scott J. Leischow et al. · Nicotine & Tobacco Research · 2006 · 72 citations

Impact of messages on concomitant use of nicotine replacement therapy and cigarettes: a randomized trial on the Internet

Jean‐François Etter, Jacques Le Houezec, Björn Landfeldt · Addiction · 2003 · 29 citations

Rows per page

1–5 of 5